Colony Group LLC Medpace Holdings, Inc. Transaction History

Colony Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 17, 2020	SELL	$92.95 - $130.61 $2.71 Million - $3.8 Million	-29,114 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$68.08 - $95.68 $8,918 - $12,534	-131 Reduced 0.45%	29,114 $2.71 Million
Q1 2020 May 18, 2020	SELL	$61.71 - $101.95 $130,146 - $215,012	-2,109 Reduced 6.73%	29,245 $2.15 Million
Q4 2019 Feb 18, 2020	SELL	$70.08 - $84.64 $15,838 - $19,128	-226 Reduced 0.72%	31,354 $2.64 Million
Q3 2019 Nov 26, 2019	BUY	$62.38 - $85.89 $28,133 - $38,736	451 Added 1.45%	31,580 $2.65 Million
Q2 2019 Aug 19, 2019	BUY	$53.64 - $65.42 $1.67 Million - $2.04 Million	31,129 New	31,129 $2.04 Million

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.3B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

Stay updated on Colony Group LLC with notifications on news.